Curet Myriam, EVP & Chief Medical Officer, has demonstrated a clear selling bias in recent insider transactions, particularly in Intuitive Surgical (ISRG). Since late January 2026, Myriam has executed eight sales totaling approximately $4.3 million, with the largest single transaction occurring on March 3, 2026, when $2.3 million worth of ISRG shares were sold. Additional notable dispositions include a $2.09 million sale on February 28 and a $1.17 million sale the prior day. The transactions appear systematic, with smaller sales—often in the $50,000–$65,000 range—accompanied by modest acquisitions through market purchases (coded "M"), such as the $24,086 and $26,112 purchases on March 10 and March 2, respectively.
Over their entire filing history, Myriam’s activity skews heavily toward dispositions, with $16.4 million in total sell value across 51 transactions compared to $4.1 million in buys. The recent sales, concentrated in a two-month span, suggest an acceleration in divestment. While some transactions may relate to tax obligations or scheduled sales (coded "F"), the pattern reflects a consistent reduction in ISRG exposure. No purchases have been reported since January 2026, reinforcing the directional trend. Myriam’s trades are exclusively tied to ISRG, with no activity in other securities during this period. The filings indicate disciplined execution, with no erratic swings in trade size or timing.
AI-assisted summary